Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): A randomised, open-label, parallel-group, phase 3 trial
The label includes a boxed warning regarding thyroid C-cell tumors based on rodent studies and states that Wegovy should not be used in patients with a personal or family history of medullary thyroid carcinoma or MEN 2
Pernicious anaemia usually develops over the age of 50
These properties collectively address key mechanisms involved in chronic diseases
US$ 24.36
US$ 27.80
US$ 27.30
US$ 29.69
US$ 20.84
US$ 1358.50
Sold : Login>>